Suivant

Lecture automatique

The future of CTCL therapy

2 Vues • 08/09/23
Partager
Intégrer
administrator
administrator
Les abonnés
0

Julia Jane Scarisbrick, MBChB, FRCP, MD, University Hospital Birmingham, Birmingham, UK, shares her views on the future of cutaneous T-cell lymphoma (CTCL) therapy, highlighting the unmet need for more efficacious therapies and to determine the optimal sequencing of therapies. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

Montre plus
0 commentaires sort Trier par
Commentaires de Facebook

Suivant

Lecture automatique